STOCK TITAN

[8-K] Electromed, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Electromed, Inc. disclosed that it has issued a press release reporting its financial results for the fourth quarter and fiscal year ended June 30, 2025, and furnished that press release as Exhibit 99.1 to this Form 8-K. The company also updated its investor presentation and furnished it as Exhibit 99.2, noting that the presentation may be used in meetings with investors and analysts.

The filing provides notice that the company has made results and updated presentation materials available to the market, but it does not include the financial metrics or narrative from the press release within the filing itself; interested parties must refer to the referenced exhibits for the detailed results and figures.

Electromed, Inc. ha comunicato di aver pubblicato un comunicato stampa con i risultati finanziari del quarto trimestre e dell’esercizio chiuso il 30 giugno 2025, allegando tale comunicato come Exhibt 99.1 al presente Form 8-K. La società ha inoltre aggiornato la presentazione rivolta agli investitori, depositandola come Exhibit 99.2, precisando che la presentazione potrà essere utilizzata in incontri con investitori e analisti.

Il deposito informa che i risultati e il materiale aggiornato sono stati resi disponibili al mercato, ma non include nel testo del filing le metriche finanziarie o il contenuto del comunicato; per i dettagli e i dati numerici occorre consultare gli exhibit citati.

Electromed, Inc. informó que ha emitido un comunicado de prensa con sus resultados financieros del cuarto trimestre y del ejercicio fiscal concluido el 30 de junio de 2025, y adjuntó ese comunicado como Exhibit 99.1 en este Form 8-K. La compañía también actualizó su presentación para inversores y la presentó como Exhibit 99.2, indicando que la presentación puede usarse en reuniones con inversores y analistas.

La presentación en el registro notifica que la empresa ha puesto a disposición del mercado los resultados y los materiales actualizados, pero no incorpora en el propio filing las métricas financieras ni el texto del comunicado; las partes interesadas deben consultar los exhibits referenciados para obtener los detalles y cifras.

Electromed, Inc.는 2025년 6월 30일로 종료된 회계연도 및 4분기 재무실적을 보도자료로 발표했으며, 해당 보도자료를 본 Form 8-K의 Exhibit 99.1로 제출했다고 공시했습니다. 회사는 또한 투자자 프레젠테이션을 업데이트하여 Exhibit 99.2로 제출했으며, 해당 자료는 투자자 및 애널리스트와의 미팅에서 사용될 수 있다고 명시했습니다.

이번 제출은 회사가 실적과 업데이트된 프레젠테이션 자료를 시장에 제공했음을 알리지만, 제출서류 자체에는 보도자료의 재무 지표나 서술 내용을 포함하지 않으므로 상세한 결과와 수치는 참조된 exhibit를 확인해야 합니다.

Electromed, Inc. a indiqué avoir publié un communiqué de presse présentant ses résultats financiers pour le quatrième trimestre et l’exercice clos le 30 juin 2025, et a joint ce communiqué en tant qu’Exhibit 99.1 à ce Form 8-K. La société a également mis à jour sa présentation investisseurs et l’a fournie en tant qu’Exhibit 99.2, en précisant que la présentation peut être utilisée lors de réunions avec des investisseurs et des analystes.

Le dépôt informe que la société a rendu les résultats et les supports mis à jour disponibles au marché, mais n’intègre pas les indicateurs financiers ni le texte du communiqué dans le filing lui‑même ; les parties intéressées doivent se référer aux exhibits mentionnés pour obtenir les résultats détaillés et les chiffres.

Electromed, Inc. gab bekannt, eine Pressemitteilung mit den Finanzergebnissen für das vierte Quartal und das am 30. Juni 2025 endende Geschäftsjahr herausgegeben zu haben, und fügte diese Pressemitteilung als Exhibit 99.1 zu diesem Form 8-K bei. Das Unternehmen hat außerdem seine Investorenpräsentation aktualisiert und als Exhibit 99.2 eingereicht, wobei vermerkt wurde, dass die Präsentation in Treffen mit Investoren und Analysten verwendet werden kann.

Die Einreichung teilt mit, dass die Ergebnisse und aktualisierten Präsentationsunterlagen dem Markt zur Verfügung gestellt wurden, enthält jedoch nicht die finanziellen Kennzahlen oder den Text der Pressemitteilung im Filing selbst; Interessierte müssen die genannten Exhibits für detaillierte Ergebnisse und Zahlen einsehen.

Positive
  • Press release furnished as Exhibit 99.1, indicating the company reported fourth-quarter and fiscal-year results
  • Updated investor presentation furnished as Exhibit 99.2, signaling active investor communications and transparency
Negative
  • The 8-K does not include the actual financial metrics or narrative; readers must consult the exhibits for substantive detail
  • No summary of results or key figures is provided in the filing text, limiting standalone usefulness of the 8-K

Insights

TL;DR: Routine disclosure of quarterly and fiscal-year results plus an updated investor deck; no financial details included in the filing itself.

The company furnished a press release reporting fourth-quarter and full-year results and updated its investor presentation. As a routine 8-K disclosure, this signals timely dissemination of results and investor materials but does not allow evaluation of performance because the filing omits the underlying numbers and metrics. For valuation or performance assessment, review Exhibit 99.1 and Exhibit 99.2.

TL;DR: Disclosure practices are consistent with Regulation FD and Form 8-K requirements; exhibits hold the substantive information.

Providing the press release and investor presentation as exhibits is standard practice to ensure broad disclosure while maintaining concise Form 8-K text. The company explicitly states the presentation may be used in investor meetings, which supports transparency. The filing itself contains no governance issues or executive actions; it functions as a notice of furnished materials.

Electromed, Inc. ha comunicato di aver pubblicato un comunicato stampa con i risultati finanziari del quarto trimestre e dell’esercizio chiuso il 30 giugno 2025, allegando tale comunicato come Exhibt 99.1 al presente Form 8-K. La società ha inoltre aggiornato la presentazione rivolta agli investitori, depositandola come Exhibit 99.2, precisando che la presentazione potrà essere utilizzata in incontri con investitori e analisti.

Il deposito informa che i risultati e il materiale aggiornato sono stati resi disponibili al mercato, ma non include nel testo del filing le metriche finanziarie o il contenuto del comunicato; per i dettagli e i dati numerici occorre consultare gli exhibit citati.

Electromed, Inc. informó que ha emitido un comunicado de prensa con sus resultados financieros del cuarto trimestre y del ejercicio fiscal concluido el 30 de junio de 2025, y adjuntó ese comunicado como Exhibit 99.1 en este Form 8-K. La compañía también actualizó su presentación para inversores y la presentó como Exhibit 99.2, indicando que la presentación puede usarse en reuniones con inversores y analistas.

La presentación en el registro notifica que la empresa ha puesto a disposición del mercado los resultados y los materiales actualizados, pero no incorpora en el propio filing las métricas financieras ni el texto del comunicado; las partes interesadas deben consultar los exhibits referenciados para obtener los detalles y cifras.

Electromed, Inc.는 2025년 6월 30일로 종료된 회계연도 및 4분기 재무실적을 보도자료로 발표했으며, 해당 보도자료를 본 Form 8-K의 Exhibit 99.1로 제출했다고 공시했습니다. 회사는 또한 투자자 프레젠테이션을 업데이트하여 Exhibit 99.2로 제출했으며, 해당 자료는 투자자 및 애널리스트와의 미팅에서 사용될 수 있다고 명시했습니다.

이번 제출은 회사가 실적과 업데이트된 프레젠테이션 자료를 시장에 제공했음을 알리지만, 제출서류 자체에는 보도자료의 재무 지표나 서술 내용을 포함하지 않으므로 상세한 결과와 수치는 참조된 exhibit를 확인해야 합니다.

Electromed, Inc. a indiqué avoir publié un communiqué de presse présentant ses résultats financiers pour le quatrième trimestre et l’exercice clos le 30 juin 2025, et a joint ce communiqué en tant qu’Exhibit 99.1 à ce Form 8-K. La société a également mis à jour sa présentation investisseurs et l’a fournie en tant qu’Exhibit 99.2, en précisant que la présentation peut être utilisée lors de réunions avec des investisseurs et des analystes.

Le dépôt informe que la société a rendu les résultats et les supports mis à jour disponibles au marché, mais n’intègre pas les indicateurs financiers ni le texte du communiqué dans le filing lui‑même ; les parties intéressées doivent se référer aux exhibits mentionnés pour obtenir les résultats détaillés et les chiffres.

Electromed, Inc. gab bekannt, eine Pressemitteilung mit den Finanzergebnissen für das vierte Quartal und das am 30. Juni 2025 endende Geschäftsjahr herausgegeben zu haben, und fügte diese Pressemitteilung als Exhibit 99.1 zu diesem Form 8-K bei. Das Unternehmen hat außerdem seine Investorenpräsentation aktualisiert und als Exhibit 99.2 eingereicht, wobei vermerkt wurde, dass die Präsentation in Treffen mit Investoren und Analysten verwendet werden kann.

Die Einreichung teilt mit, dass die Ergebnisse und aktualisierten Präsentationsunterlagen dem Markt zur Verfügung gestellt wurden, enthält jedoch nicht die finanziellen Kennzahlen oder den Text der Pressemitteilung im Filing selbst; Interessierte müssen die genannten Exhibits für detaillierte Ergebnisse und Zahlen einsehen.

false 0001488917 0001488917 2025-08-26 2025-08-26
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
     
 
FORM 8-K
     
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): August 26, 2025
     
 
ELECTROMED, INC.
(Exact Name of Registrant as Specified in Its Charter)
 
Minnesota
001-34839
41-1732920
(State or Other Jurisdiction of
Incorporation)
(Commission File Number)
(I.R.S. Employer Identification
Number)
 
500 Sixth Avenue NW
New Prague, MN 56071
(Address of Principal Executive Offices) (Zip Code)
 
(952) 758-9299
(Registrant’s Telephone Number, Including Area Code)
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
     
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Common Stock, $0.01 par value
 
ELMD
 
NYSE American LLC
(Title of each class)
 
(Trading Symbol)
 
(Name of each exchange on which registered)
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 

 
 
Item 2.02
Results of Operations and Financial Condition.
 
On August 26, 2025, Electromed, Inc., a Minnesota corporation (the “Company”), issued a press release announcing its financial results for the fourth quarter and fiscal year ended June 30, 2025. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference into this Item 2.02.
 
Item 7.01
Regulation FD Disclosure.
 
The Company has updated its investor presentation, a copy of which is furnished as Exhibit 99.2 to this Current Report on Form 8-K and incorporated by reference into this Item 7.01. The Company intends to use the presentation in whole or in part, in one or more meetings with investors and analysts.
 
Item 9.01
Financial Statements and Exhibits.
 
(d) Exhibits:
 
Exhibit Number
 
Description
     
99.1
 
Press Release dated August 26, 2025
99.2
 
Company Investor Presentation dated August 26, 2025
104
 
Cover Page Interactive Data File (embedded in the cover page and formatted in inline XBRL)
 
The information contained in this Current Report on Form 8-K, including Exhibits 99.1 and 99.2 attached hereto, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, and shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
 
 
 

 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
ELECTROMED, INC.
     
Date: August 26, 2025
By:
/s/ Bradley M. Nagel
 
Name:
Bradley M. Nagel
 
Title:
Chief Financial Officer
 
 
 
 

FAQ

What did Electromed (ELMD) disclose in this 8-K?

The company furnished a press release reporting its fourth-quarter and fiscal-year results for the period ended June 30, 2025, as Exhibit 99.1 and an updated investor presentation as Exhibit 99.2.

Does this 8-K include Electromed's financial results numbers?

No. The filing states the press release contains the financial results but does not reproduce those metrics in the 8-K text; review Exhibit 99.1 for the numbers.

What exhibits did Electromed file with the 8-K for ELMD?

Exhibit 99.1: Press Release reporting the fourth-quarter and fiscal-year results; Exhibit 99.2: Updated Company Investor Presentation.

Will Electromed use the updated investor presentation publicly?

Yes. The company stated it intends to use the presentation, in whole or in part, in meetings with investors and analysts.

Is there any indication of material transactions or officer changes in this 8-K for ELMD?

No. The filing only references the furnished press release and updated investor presentation and does not disclose material transactions or personnel changes.
Electromed

NYSE:ELMD

ELMD Rankings

ELMD Latest News

ELMD Latest SEC Filings

ELMD Stock Data

169.99M
6.65M
20.96%
52.93%
3.41%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
NEW PRAGUE